Helicobacter Pylori Infection

22 drugs in development·6 companies·6 clinical trials

Drug Pipeline by Phase

Approved(3)

Drug	Company
amoxicillin	Miromatrix Medical Inc. (MIRO)
clarithromycin	SUNSET ISLAND GROUP (SUN)
Clarithromycin Granules and Capsules	CHINA PHARMA HOLDINGS, INC. (CPHI)

Phase 3(3)

Phase 2(6)

Phase 4(10)

Drug	Company
14-day fecal molecular susceptibility-guided therapy	Bausch Health Companies Inc. (BHC)
7-day fecal molecular susceptibility-guided therapy	Bausch Health Companies Inc. (BHC)
Amoxicillin	INSMED Inc (INSM)
Lansoprazole, Amoxicillin, Clarithromycin and Metronidazole	INSMED Inc (INSM)
Lansoprazole, Amoxicillin, Clarithromycin and Metronidazole	CYTOKINETICS INC (CYTK)
Vonoparazan	INSMED Inc (INSM)
Vonoprazan	INSMED Inc (INSM)
Vonoprazan and Amoxicillin	INSMED Inc (INSM)
Vonoprazan and Amoxicillin	CYTOKINETICS INC (CYTK)
VOQUEZNA® Triple Pak®	INSMED Inc (INSM)

BioSniper tracks 22 drugs in development for Helicobacter Pylori Infection across 6 companies.

There are 6 clinical trials targeting Helicobacter Pylori Infection tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.